These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16960260)

  • 1. Ensuring fairness in coverage decisions: applying the American Medical Association Ethical Force Program's consensus report to managed care pharmacy.
    Teagarden JR; Wynia MK
    Am J Health Syst Pharm; 2006 Sep; 63(18):1749-54. PubMed ID: 16960260
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving fairness in coverage decisions: an application of the Ethical Force Program's recommendations on infertility treatment.
    Goldberg MK
    Am J Bioeth; 2004; 4(3):106-8; discussion W40-2. PubMed ID: 16192162
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving fairness in coverage decisions: appearance or reality?
    Baily MA
    Am J Bioeth; 2004; 4(3):110-2; discussion W40-2. PubMed ID: 16192164
    [No Abstract]   [Full Text] [Related]  

  • 4. Mythic ideals.
    Steinberg D
    Am J Bioeth; 2004; 4(3):122-3; discussion W40-2. PubMed ID: 16192170
    [No Abstract]   [Full Text] [Related]  

  • 5. Fairness in context: the real versus the ideal.
    Slomka J
    Am J Bioeth; 2004; 4(3):115-6; discussion W40-2. PubMed ID: 16192167
    [No Abstract]   [Full Text] [Related]  

  • 6. Measuring fairness: an opportunity for empirical ethics.
    Light DW
    Am J Bioeth; 2004; 4(3):105-6; discussion W40-2. PubMed ID: 16192161
    [No Abstract]   [Full Text] [Related]  

  • 7. Wanted: more assistance in benefits design.
    Gervais KG; Garrett JE
    Am J Bioeth; 2004; 4(3):119-21; discussion W40-2. PubMed ID: 16192169
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving fairness in coverage decisions: insights from the Harvard Community Health Plan's LORAN Commission Report.
    Paris JJ
    Am J Bioeth; 2004; 4(3):103-4; discussion W40-2. PubMed ID: 16192160
    [No Abstract]   [Full Text] [Related]  

  • 9. The ethical quality report card: confronting rationing.
    Strosberg MA
    Am J Bioeth; 2004; 4(3):114-5; discussion W40-2. PubMed ID: 16192166
    [No Abstract]   [Full Text] [Related]  

  • 10. Supplementing the fairness framework: system-level and implementation concerns.
    Majumder MA
    Am J Bioeth; 2004; 4(3):112-4; discussion W40-2. PubMed ID: 16192165
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving fairness in coverage decisions: performance expectations for quality improvement.
    Wynia MK; Cummins D; Fleming D; Karsjens K; Orr A; Sabin J; Saphire-Bernstein I; Witlen R;
    Am J Bioeth; 2004; 4(3):87-100. PubMed ID: 16192158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical justice guiding medical allocations.
    Rhodes R
    Am J Bioeth; 2004; 4(3):116-9; discussion W40-2. PubMed ID: 16192168
    [No Abstract]   [Full Text] [Related]  

  • 13. Obligations and marginal decisions in a fair health system.
    Berger JT
    Am J Bioeth; 2004; 4(3):123-4; discussion W40-2. PubMed ID: 16192171
    [No Abstract]   [Full Text] [Related]  

  • 14. The elephant in the living room of the house of health care.
    Lamm RD
    Am J Bioeth; 2004; 4(3):101-2; discussion W40-2. PubMed ID: 16192159
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare coverage for technological innovations.
    Wynia MK; Witlen R
    N Engl J Med; 2004 Aug; 351(7):719-20; author reply 719-20. PubMed ID: 15306678
    [No Abstract]   [Full Text] [Related]  

  • 16. Checklist to choose a health plan.
    S C Nurse (1994); 2014; 21(1):3. PubMed ID: 24851502
    [No Abstract]   [Full Text] [Related]  

  • 17. Funding for spinal cord injuries in a managed care setting: money ($) equals outcomes.
    Romano JL
    SCI Nurs; 1999 Sep; 16(3):89-92. PubMed ID: 10855211
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond the lies: solving the problem.
    Morreim EH
    Am J Bioeth; 2004; 4(4):61-3. PubMed ID: 16192210
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing heterogeneity in prescription drug coverage policies.
    Teagarden JR
    J Manag Care Spec Pharm; 2014 Jun; 20(6):564-5. PubMed ID: 24856594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Medicare prescription drug benefit: focusing on coverage and cost.
    Cubanski J; Kline J
    Issue Brief (Commonw Fund); 2002 Apr; (538):1-6. PubMed ID: 11993504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.